A report by the OECD reveals that most national authorities want more international transparency when it comes to the ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the ...

Walgreens was accused of wrongly requiring insured customers to pay more than members of its Prescription Savings Club.

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

Business owners in downtown Fredericton say they are increasingly frustrated with a rise in break-ins, theft, vandalism, open ...

I have a real problem with the science behind the DRE,” said attorney Chris Langholz. “It’s junk science and it shouldn’t be ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...